TY - JOUR
T1 - A novel PAK3 pathogenic variant identified in two siblings from a Japanese family with X-linked intellectual disability
T2 - Case report and review of the literature
AU - Iida, Aritoshi
AU - Takano, Kyoko
AU - Takeshita, Eri
AU - Abe-Hatano, Chihiro
AU - Hirabayashi, Shinichi
AU - Inaba, Yuji
AU - Kosugi, Shunichi
AU - Kamatani, Yoichiro
AU - Momozawa, Yukihide
AU - Kubo, Michiaki
AU - Nakagawa, Eiji
AU - Inoue, Ken
AU - Goto, Yu Ichi
N1 - Publisher Copyright:
© 2019 Iida et al.
PY - 2019
Y1 - 2019
N2 - Intellectual disability (ID) is a clinically and genetically heterogeneous developmental brain disorder. The present study describes two male siblings, aged 7 and 1 yr old, with severe ID, spastic quadriplegia, nystagmus, and brain atrophy with acquired microcephaly. We used the exome sequencing to identify the causative gene in the patients and identified a hemizygous missense variant, c.1282T>A (p.W428R), in the p21-activated serine/ threonine kinase 3 gene (PAK3), which is associated with X-linked ID. p.W428R is located within the highly conserved kinase domain and was predicted to induce loss of enzymatic function by three mutation prediction tools (SIFT, PolyPhen-2, and MutationTaster). In addition, this variant has not been reported in public databases (as of the middle of December 2018) or in the data from3275 individuals of the Japanese general population analyzed using high-depth whole-genome sequencing. To date, only 13 point mutations and deletions in PAK3 in ID have been reported. The literature review illustrated a phenotypic spectrum of PAK3 pathogenic variant, and our cases represented the most severe form of the PAK3-associated phenotypes. This is the first report of a PAK3 pathogenic variant in Japanese patients with X-linked ID.
AB - Intellectual disability (ID) is a clinically and genetically heterogeneous developmental brain disorder. The present study describes two male siblings, aged 7 and 1 yr old, with severe ID, spastic quadriplegia, nystagmus, and brain atrophy with acquired microcephaly. We used the exome sequencing to identify the causative gene in the patients and identified a hemizygous missense variant, c.1282T>A (p.W428R), in the p21-activated serine/ threonine kinase 3 gene (PAK3), which is associated with X-linked ID. p.W428R is located within the highly conserved kinase domain and was predicted to induce loss of enzymatic function by three mutation prediction tools (SIFT, PolyPhen-2, and MutationTaster). In addition, this variant has not been reported in public databases (as of the middle of December 2018) or in the data from3275 individuals of the Japanese general population analyzed using high-depth whole-genome sequencing. To date, only 13 point mutations and deletions in PAK3 in ID have been reported. The literature review illustrated a phenotypic spectrum of PAK3 pathogenic variant, and our cases represented the most severe form of the PAK3-associated phenotypes. This is the first report of a PAK3 pathogenic variant in Japanese patients with X-linked ID.
UR - http://www.scopus.com/inward/record.url?scp=85076505499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076505499&partnerID=8YFLogxK
U2 - 10.1101/mcs.a003988
DO - 10.1101/mcs.a003988
M3 - Review article
C2 - 31444167
AN - SCOPUS:85076505499
SN - 2373-2873
VL - 5
JO - Cold Spring Harbor Molecular Case Studies
JF - Cold Spring Harbor Molecular Case Studies
IS - 6
M1 - a003988
ER -